ESC Premium Access

Controversies in heart failure

Event: ESC CONGRESS 2016
Topic: Pathophysiology and diagnosis
Session type: Debate Session
Date: 27 August 2016
Time: 11:00 - 12:30

Session

6 presentations in this session

Controversies in heart failure - Introduction to the session

Speaker: Doctor C. Yancy (Chicago, US)
Thumbnail

ACE - inhibitors should be replaced by LCZ696 as first line therapy for heart failure - PRO

Speaker: Professor J. McMurray (Glasgow, GB)
Thumbnail

ACE - inhibitors should be replaced by LCZ696 as first line therapy for heart failure - CON

Speaker: Professor G. Rosano (London, GB)
Thumbnail

B-Blockers and digoxin should be forgotten in atrial fibrillation heart failure - PRO

Speaker: Professor S. Hohnloser (Frankfurt, DE)
Thumbnail

B-Blockers and digoxin should be forgotten in atrial fibrillation heart failure - CON

Speaker: Professor J. Bauersachs (Hannover, DE)
Thumbnail

Controversies in heart failure - Conclusion

Speaker: Professor S. Anker (Berlin, DE)
Thumbnail

6 speakers from this session

Doctor Clyde Yancy

Northwestern University, Chicago (United States of America)
8 presentations
0 follower

Professor John J V McMurray

Western Infirmary, Glasgow (United Kingdom of Great Britain & Northern Ireland)
82 presentations
2 followers

Professor Giuseppe M C Rosano

St Georges Medical School, London (United Kingdom of Great Britain & Northern Ireland)
59 presentations
5 followers

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)
27 presentations
1 follower

Professor Johann Bauersachs

Hannover Medical School, Hannover (Germany)
27 presentations
1 follower

Professor Stefan Anker

Charite Campus Virchow Clinic, Berlin (Germany)
106 presentations
2 followers

This platform is supported by

logo Novo Nordisk